Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

RxSight (RXST) Leases (2020 - 2026)

RxSight filings provide 6 years of Leases readings, the most recent being $10.0 million for Q4 2025.

  • On a quarterly basis, Leases fell 11.22% to $10.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.0 million, a 11.22% decrease, with the full-year FY2025 number at $10.0 million, down 11.22% from a year prior.
  • Leases hit $10.0 million in Q4 2025 for RxSight, down from $10.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $11.2 million in Q4 2024 to a low of $2.1 million in Q1 2024.
  • Median Leases over the past 5 years was $4.6 million (2021), compared with a mean of $6.3 million.
  • Biggest five-year swings in Leases: crashed 42.28% in 2024 and later surged 432.26% in 2025.
  • RxSight's Leases stood at $4.3 million in 2021, then dropped by 7.96% to $3.9 million in 2022, then tumbled by 38.02% to $2.4 million in 2023, then skyrocketed by 358.96% to $11.2 million in 2024, then decreased by 11.22% to $10.0 million in 2025.
  • The last three reported values for Leases were $10.0 million (Q4 2025), $10.3 million (Q3 2025), and $10.6 million (Q2 2025) per Business Quant data.